Optimal use of methotrexate: the advantages of tight control.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 17934080.
- Also identified by PMC identifier 2111621.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The CAMERA study shows that using methotrexate in a tight control setting might lead to considerable improvement in disease activity in early rheumatoid arthritis See linked article p 1443.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Methotrexate